1. Home
  2. MMS vs CORT Comparison

MMS vs CORT Comparison

Compare MMS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maximus Inc.

MMS

Maximus Inc.

HOLD

Current Price

$78.06

Market Cap

4.3B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$34.12

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMS
CORT
Founded
1975
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.7B
IPO Year
1997
2001

Fundamental Metrics

Financial Performance
Metric
MMS
CORT
Price
$78.06
$34.12
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$105.20
AVG Volume (30 Days)
734.6K
1.7M
Earning Date
05-07-2026
05-25-2026
Dividend Yield
1.69%
N/A
EPS Growth
10.42
N/A
EPS
1.70
0.82
Revenue
$2,392,236,000.00
$761,407,000.00
Revenue This Year
$0.44
$29.97
Revenue Next Year
$5.15
$30.25
P/E Ratio
$45.89
$41.48
Revenue Growth
N/A
12.79
52 Week Low
$64.68
$28.66
52 Week High
$100.00
$117.33

Technical Indicators

Market Signals
Indicator
MMS
CORT
Relative Strength Index (RSI) 46.65 34.22
Support Level $77.59 $33.53
Resistance Level $89.28 $41.92
Average True Range (ATR) 2.32 2.46
MACD 1.04 0.27
Stochastic Oscillator 82.88 45.15

Price Performance

Historical Comparison
MMS
CORT

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: